Predictive Biomarkers in Oncology
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Laboratory Medicine".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 142
Special Issue Editor
Interests: biomarker and its clinical application; development of new automation technique for clinical diagnosis; personal diagnosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Advances in precision medicine have highlighted the critical role of predictive biomarkers in oncology, enabling tailored therapies and improving patient outcomes. This Special Issue focuses on the discovery, validation, and clinical application of biomarkers that predict treatment response, resistance, and prognosis in cancer. We invite original research, reviews, and perspectives on cutting-edge technologies (e.g., genomics, proteomics, liquid biopsy) and their integration into clinical decision making. Topics include novel biomarker identification, computational modeling, and translational challenges in diverse cancer types. By compiling the latest advancements, this Special Issue aims to foster innovation in personalized oncology and guide future research directions.
Prof. Dr. Jun Zhang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- predictive biomarkers
- precision oncology
- liquid biopsy
- treatment response
- biomarker validation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
